U.S., July 18 -- ClinicalTrials.gov registry received information related to the study (NCT07711782) titled 'Management of Polycystic Ovarian Syndrome-associated Reproductive Dysfunction Through Kefir Supplementation' on July 13.

Brief Summary: Polycystic ovary syndrome (PCOS) affect around 6-12% of women of age 18-25 years. Kefir contains bioactive compounds such as lactic acid bacteria, yeast, peptides, polysaccharides and organic acids and acts as a good probiotic source.

Study Start Date: Jan. 18

Study Type: INTERVENTIONAL

Condition: Polycystic Ovarian Syndrome (PCOS) Reproductive Health

Intervention: OTHER: (C0) Control group

Participants were subjected to use a regular calorie deficit diet plan

DIETARY_SUPPLEMENT: (G1) Experi...